Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
NIIMBL Announces $4.6M to Fund 10 New Biopharmaceutical Manufacturing Projects
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announce funding for […]
ViAqua Therapeutics Announces $4.3 Million Investment for RNA-based Aquaculture Health Platform
ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and […]
Blueberry Therapeutics Secures £750,000 Investment from NPIF - Maven Equity Fund
NPIF – Maven Equity Finance, managed by Maven Capital Partners (“Maven”) and part of the […]
UnitedHealthcare Awards $275,000 in Maternal Health Grants to Seven Community Organizations in Louisiana
UnitedHealthcare Community Plan of Louisiana has awarded $275,000 in maternal health grants to seven community […]
Helix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral Surveillance
Helix, the leading population genomics and COVID-19 testing company, has closed on its Series C […]
The Bill & Melinda Gates Foundation Pledges $50 Million to Increase Access to Safe and Affordable COVID-19 Vaccines in Lower-income Countries
The Bill & Melinda Gates Foundation today announced a $50 million commitment to Gavi, the […]
Ada Health Secures £63m Investment to Enhance Assessment Tech
Ada Health has secured $90m (£63m) in funding to enhance its health assessment technology. The […]
Leaps by Bayer Leads USD 90 Million Series B Financing in Digital Health Company Ada Health
Leaps by Bayer, the impact investment arm of Bayer AG, today announces that it has […]
Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital Therapeutics
Akili Interactive (“Akili” or “Company”), maker of EndeavorRx™, the first and only prescription video game […]
Esco Lifesciences Closes a Record-Setting US$200M Series A Round Led by Vivo Capital and Novo Holdings
Esco Lifesciences (“Esco”, the “Company”) announced today the close of an over-subscribed US$200 million Series A and Crossover […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more